Picture of Prothena logo

PRTA — Prothena News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Prothena Corporation PLC reports results for the quarter ended December 31 - Earnings Summary

* Prothena Corporation PLC  PRTA.OQ  reported a quarterly
adjusted
loss of $1.08​​ per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of $-1.26.  The mean expectation of nine analysts
for the quarter was for a loss of $1.04 per share. Wall Street
expected results to range from $-1.22 to -58 cents per share.
    * Revenue rose 571.8% to $2.12 million from a year ago;
analysts
expected $7.53 million. 
    * Prothena Corporation PLC's reported EPS for the quarter
was a
loss of $1.08​.
    * The company reported a quarterly loss of $57.96 million.
    * Prothena Corporation PLC shares had risen by 8.2% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Prothena
Corporation PLC is $44.00 
This summary was machine generated from LSEG data February 21 at
12:49 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -1.04          -1.08          Missed
 Sep. 30 2024      -1.18          -1.10          Beat
 Jun. 30 2024      -1.05          1.22           Beat
 Mar. 31 2024      -1.20          -1.34          Missed

Recent news on Prothena

See all news